4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-23-020573
Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)
- Chief Scientific Officer acquired 9,092 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-07 | Sale : show line 1 in the form 10b5-1 | −1,306 | $0.36 | $470 | 62,781 | D |
| 2023-07-07 | Exercise or conversion : show line 2 in the form 10b5-1 | +4,546 | 67,327 | D | ||
| 2023-07-10 | Sale : show line 3 in the form 10b5-1 | −1,304 | $0.37 | $482 | 66,023 | D |
| 2023-07-10 | Exercise or conversion : show line 4 in the form 10b5-1 | +4,546 | 70,569 | D | ||
| Open-market sales · 2,610 sh · avg $0.36 · $953 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Underlying | Owned after | D/I |
|---|---|---|---|---|---|
| 2023-07-07 | Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit | −4,546 | 4,546 | 136,362 | D |
| 2023-07-10 | Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Unit | −4,546 | 4,546 | 131,816 | D |
Loading xslF345X04/form4.xml…